Navigation Links
rBChE in Medical Technology

PharmAthene Presents Data for Protexia(R) and Valortim(R) at 2008 BARDA Industry Conference / PHEMCE Stakeholders Workshop

...provides new data that suggests that the pegylated rbche (Protexia(R)) may have efficacy as a therapeutic a...ax. Summary of Data Presented: Non-pegylated rbche Findings Reported In a poster entitled, "Recombi...investigators studied the effects of non-pegylated rbche administered following poisoning by VX in an anima...

PharmAthene's Recombinant Butyrylcholinesterase (rBChE) May Play A Neuroprotective Role in Alzheimer's Disease

...llaboration with PharmAthene, examined the role of rbche in the prevention of amyloid plaques, which are be...cially intriguing as they continue to suggest that rbche is effective not only in inhibiting plaque formati...accumulating data provide compelling evidence that rbche may serve as a natural protector against amyloid t...

PharmAthene's Recombinant Butyrylcholinesterase (rBChE) Program the Subject of Promising New Alzheimer's Research

... In Vitro Assays Show rbche Suppresses Amyloid Plaque Formation ANNAPOLIS, Md...hief Scientific Officer for PharmAthene, show that rbche can effectively block the formation of amyloid fib...ion electron microscopy studies, which showed that rbche dramatically suppressed the formation of fibrils, ...

Pharmathene's Recombinant Butyrylcholinesterase (rBChE) Program the Subject of Promising New Alzheimer's Research

... In Vitro Assays Show rbche Suppresses Amyloid Plaque Formation ANNAPOLIS, M...hief Scientific Officer for PharmAthene, show that rbche can effectively block the formation of amyloid fib...ion electron microscopy studies, which showed that rbche dramatically suppressed the formation of fibrils, ...
rBChE in Biological Technology

PharmAthene Completes Pharmacokinetic Studies of Protexia(R); Program on Target for IND Filing in 2008

...al species and used the final pegylated version of rbche for the first time. In general, the conjugation of...rm that the specific PEG chosen for conjugation to rbche will significantly improve the half-life of the pr...half life data also confirm that the pegylation of rbche as part of our manufacturing process achieved the ...
Other Tags
(Date:7/25/2014)... July 24, 2014 (HealthDay News) -- Shift workers, especially men, ... to people not on such schedules, a new study suggests. ... work on a set schedule, with shifts moving around at ... at all surprising," said one expert, Dr. Alan Manevitz, a ... "Physicians have long known that working shifts disrupts many ...
(Date:7/25/2014)... experimental anti-inflammatory drug can protect vulnerable neurons and ... Parkinson,s disease, researchers at Emory University School of ... in the Journal of Parkinson,s Disease . ... XPro1595, can reach the brain at sufficient levels ... injection, like an insulin shot. Previous studies of ...
(Date:7/25/2014)... Newyorktermlifeinsurance.org has released a new ... and traditional policies. , The newly released blog ... no medical exam life insurance plans and traditional policies. ... insurance plans to provide a simple guide for purchasing ... can now be purchased online. Although traditional plans do ...
(Date:7/25/2014)... (PRWEB) July 25, 2014 CarePoint Health ... Dr. Edward Boylan, has joined our network, CarePoint Health ... community. Hundreds of highly skilled and experienced physicians comprise ... doctors and practices in Hudson County, representing a wide ... commitment to provide the highest quality care to patients ...
(Date:7/25/2014)... 25, 2014 The Rottenstein Law ... with over 25 years of experience advocating for ... prescription drugs, announces the launch of its new ... those who believe they have been harmed by ... offers valuable information about the severe adverse side ...
Breaking Medicine News(10 mins):Health News:Study Links Shift Work to Risk for Type 2 Diabetes 2Health News:Study Links Shift Work to Risk for Type 2 Diabetes 3Health News:Anti-inflammatory drug can prevent neuron loss in Parkinson's model 2Health News:No Medical Exam Life Insurance and Traditional Plans - Newyorktermlifeinsurance.org Provides Quotes for All Types of Life Insurance 2Health News:Dr. Boylan Joins CarePoint Health Medical Group 2Health News:Rottenstein Law Group LLP Announces Launch of Xarelto Injury Website 2
(Date:7/24/2014)... -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) (the "Company") announced the ... Phase 3 study of Zerenex (ferric citrate), the Company,s ... of hyperphosphatemia in patients with end-stage renal disease (ESRD) ... delivery with FErric CiTrate in EsrD) was published online ... of Nephrology ( JASN ). , ...
(Date:7/24/2014)... have decreased by 45% on average over a 35 ... a study on the impact of humans on declining ... benefits invertebrates such as insects, spiders, crustaceans, slugs and ... pest control for crops, decomposition for nutrient cycling, water ... Science and led by UCL, Stanford and ...
(Date:7/24/2014)... 3.5 billion years of evolutionary trial and error, is ... may be reaching a tipping point. , In a ... published in Science , an international team of ... is contributing to what appears to be the early ... , Since 1500, more than 320 terrestrial vertebrates have ...
Breaking Biology News(10 mins):Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 4Invertebrate numbers nearly halve as human population doubles 2Invertebrate numbers nearly halve as human population doubles 3Stanford biologist warns of early stages of Earth's 6th mass extinction event 2Stanford biologist warns of early stages of Earth's 6th mass extinction event 3
Other Contents